Literature DB >> 3955555

Cisplatin in patients with gastric cancer: a Cancer and Leukemia Group B phase II study.

M C Perry, M R Green, R Mick, P Schein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3955555

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Status of treatment for advanced gastric carcinoma.

Authors:  James Y Tsai; Howard Safran
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

2.  Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.

Authors:  A S Goldenberg; D Kelsen; J Dougherty; G Magill
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

3.  Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers.

Authors:  T Furukawa; K Kumai; T Kubota; S Hirahata; H Shimizu; H Matsui; T Takahara; K Aizawa; S Shibata; A Shimada
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.

Authors:  H J Kang; H M Chang; T W Kim; M-H Ryu; H J Sohn; J H Yook; S T Oh; B S Kim; J-S Lee; Y-K Kang
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.